The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Wang, Jianbo ^a   Jia, Yibin ^a   Wang, Nana ^a   Zhang, Xiaomei ^a   Tan, Bingxu ^a   Zhang, Guangyu ^a   Cheng, Yufeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Esophageal squamous cell carcinoma; Immunohistochemistry; Intratumoral neutrophils; Microenvironment; Neturophil to CD8+ lymphocyte ratio

Indexed keywords

CD66B ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CD8+ T LYMPHOCYTE; CELL DENSITY; CELLULAR DISTRIBUTION; CELLULAR PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL; NEUTROPHIL TO CD8+ T LYMPHOCYTE RATIO; OVERALL SURVIVAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ASSOCIATED NEUTROPHIL; TUMOR MICROENVIRONMENT; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL INFILTRATION;

EID: 84892149602     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-12-7     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. Ca Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. MAO YS, HE J, Cheng GY. Current status of surgical management of esophageal cancer in china and the future strategy. Zhonghua Zhong Liu Za Zhi 2010, 32:401-404.
3. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007, 25:4110-4117. 10.1200/JCO.2007.12.0881, 17827461.
4. Cheng TH, Hsu PK, Li AF, Hung IC, Huang MH, Hsu HS. Correlation of p53, MDM2 and p14(ARF) protein expression in human esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2009, 135:1577-1582. 10.1007/s00432-009-0605-5, 19488782.
5. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006, 6:715-727. 10.1038/nri1936, 16977338.
6. Bremnes RM, Al-Shibli K, Donnem T, Sirera R, Al-Saad S, Andersen S, Stenvold H, Camps C, Busund LT. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol 2011, 6:824-833. 10.1097/JTO.0b013e3182037b76, 21173711.
7. Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 2011, 71:2411-2416. 10.1158/0008-5472.CAN-10-2583, 21427354.
8. Hofman PM. Pathobiology of the neutrophil-intestinal epithelial cell interaction: role in carcinogenesis. World J Gastroenterol 2010, 16:5790-5800. 10.3748/wjg.v16.i46.5790, 3001969, 21154999.
9. Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, Von Der Maase H. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 2009, 27:4709-4717. 10.1200/JCO.2008.18.9498, 19720929.
10. Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS, Xu YF. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol 2011, 54:497-505. 10.1016/j.jhep.2010.07.044, 21112656.
11. Rao HL, Chen JW, Li M, Xiao YB, Fu J, Zeng YX, Cai MY, Xie D. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. Plos One 2012, 7:E30806. 10.1371/journal.pone.0030806, 3266280, 22295111.
12. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420:860-867. 10.1038/nature01322, 2803035, 12490959.
13. Mcmillan DC, Canna K, Mcardle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg 2003, 90:215-219. 10.1002/bjs.4038, 12555298.
14. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001, 102:5-14.
15. Mcmillan DC, Wotherspoon HA, Fearon KC, Sturgeon C, Cooke TG, Mcardle CS. A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg 1995, 170:319-322. 10.1016/S0002-9610(99)80296-7, 7573721.
16. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 2011, 18:3362-3369. 10.1245/s10434-011-1754-8, 3192937, 21547702.
17. Hsu PK, Wu YC, Chou TY, Huang CS, Hsu WH. Comparison of the 6th and 7th editions of the American joint committee on cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma. Ann Thorac Surg 2010, 89:1024-1031. 10.1016/j.athoracsur.2010.01.017, 20338302.
18. ANDO N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan clinical oncology group study-JCOG9204. J Clin Oncol 2003, 21:4592-4596. 10.1200/JCO.2003.12.095, 14673047.
19. Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coelle C, Mouroux J, Hofman P. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 2012, 118:1726-1737. 10.1002/cncr.26456, 21953630.
20. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444. 10.1038/nature07205, 18650914.
21. Houghton AM. The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 2010, 9:1732-1737. 10.4161/cc.9.9.11297, 20404546.
22. Zhao JJ, Pan K, Wang W, Chen JG, Wu YH, Lv L, Li JJ, Chen YB, Wang DD, Pan QZ, et al. The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. Plos One 2012, 7:E33655. 10.1371/journal.pone.0033655, 3307751, 22442706.
23. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, Worthen GS, Albelda SM. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194. 10.1016/j.ccr.2009.06.017, 2754404, 19732719.
24. Gungor N, Knaapen AM, Munnia A, Peluso M, Haenen GR, Chiu RK, Godschalk RW, VAN Schooten FJ. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010, 25:149-154. 10.1093/mutage/gep053, 19892774.
25. Houghton AM, Rzymkiewicz DM, JI H, Gregory AD, EGEA EE, Metz HE, Stolz DB, Land SR, Marconcini LA, Kliment CR, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 2010, 16:219-223. 10.1038/nm.2084, 2821801, 20081861.
26. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490. 10.1016/S0092-8674(00)00139-2, 2843102, 11081634.
27. Gutierrez-Fernandez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL, Jones JL, SPAN PN, et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 2008, 68:2755-2763. 10.1158/0008-5472.CAN-07-5154, 18413742.
28. Shanker A, Verdeil G, Buferne M, Inderberg-Suso EM, Puthier D, Joly F, Nguyen C, Leserman L, Auphan-Anezin N, Schmitt-Verhulst AM. CD8 T cell help for innate antitumor immunity. J Immunol 2007, 179:6651-6662.
29. Williams MA, Bevan MJ. Effector and memory CTL differentiation. Annu Rev Immunol 2007, 25:171-192. 10.1146/annurev.immunol.25.022106.141548, 17129182.
30. Gooden MJ, DE Bock GH, Leffers N, Daemen T, Nijman HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 2011, 105:93-103. 10.1038/bjc.2011.189, 3137407, 21629244.
31. Ikeguchi M, Saito H, Katano K, Tsujitani S, Maeta M, Kaibara N. Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. Oncology 1997, 54:311-317. 10.1159/000227709, 9216856.
32. Schumacher K, Haensch W, Roefzaad C, Schlag PM. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 2001, 61:3932-3936.
33. Cho Y, Miyamoto M, Kato K, Fukunaga A, Shichinohe T, Kawarada Y, Hida Y, Oshikiri T, Kurokawa T, Suzuoki M, et al. CD4+ And CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 2003, 63:1555-1559.
34. Zingg U, Montani M, Frey DM, Dirnhofer S, Esterman AJ, Went P, Oertli D. Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus. Eur J Surg Oncol 2010, 36:670-677. 10.1016/j.ejso.2010.05.012, 20510571.
35. Prado-Garcia H, Romero-Garcia S, Aguilar-Cazares D, Meneses-Flores M, lopez-gonzalez JS. Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Clin Dev Immunol 2012, 2012:741741. 3483679, 23118782.
36. Roxburgh C, Mcmillan D. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010, 6:149-163. 10.2217/fon.09.136, 20021215.